Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
by
Starzer, Angelika M.
, Berghoff, Anna S.
, Preusser, Matthias
in
Cancer
/ Immune checkpoint inhibitors
/ Immune evasion
/ Immune response
/ Immunity (Disease)
/ Review
/ Tumors
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
by
Starzer, Angelika M.
, Berghoff, Anna S.
, Preusser, Matthias
in
Cancer
/ Immune checkpoint inhibitors
/ Immune evasion
/ Immune response
/ Immunity (Disease)
/ Review
/ Tumors
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
Journal Article
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
2022
Request Book From Autostore
and Choose the Collection Method
Overview
The introduction of immune checkpoint inhibitors has changed the therapeutic possibilities for various cancer types. However, despite the success in some entities, a significant fraction of patients does not respond to immune checkpoint inhibitors. A functioning cancer-immunity cycle is needed as the precondition for a clinically meaningful response to immune checkpoint inhibitors. It is assumed that only if each step of the cycle is activated and functioning properly, immune checkpoint inhibitors induce a meaningful immune response. However, an activated cancer-immunity cycle might not be present equally in each patient and cancer type. Ideally, treatment concepts should consider each single step of the cancer-immunity cycle and provide personalized treatment approaches, allowing the adaption to functioning and malfunctioning steps of the individual patient’s specific cancer-immunity cycle. In the following review, we provide an overview of the single steps of the cancer-immunity cycle as well as the impact of malfunctioning steps on the generation of an effective tumor-specific immune response.
Publisher
SAGE Publications,Sage Publications Ltd,SAGE Publishing
Subject
This website uses cookies to ensure you get the best experience on our website.